Point of care

GenXys HealthCare Systems announces completion of oversubscribed seed round financing to enable continued market penetration with acclaimed precision prescribing software

Retrieved on: 
Monday, March 1, 2021

GenXys provides evidence-based medication decision support tools with embedded pharmacogenetics to enable precision prescribing seamlessly at the point of care.

Key Points: 
  • GenXys provides evidence-based medication decision support tools with embedded pharmacogenetics to enable precision prescribing seamlessly at the point of care.
  • The award-winning suite of clinical decision support software including TreatGx and ReviewGx is now interoperable with electronic health record systems and is pharmacogenetic test agnostic.
  • GenXys, with global headquarters in Vancouver Canada, provides the world's most comprehensive precision prescribing solutions with embedded pharmacogenetics to solve one of healthcare's biggest challenges; inappropriate ("trial-and-error") prescribing.
  • Their clinical decision support software suite is in use by major insurance providers, health systems and pharmacies across North America.

Tift Regional Medical Center Accelerates Sepsis Detection with POC Advisor from Wolters Kluwer

Retrieved on: 
Wednesday, February 17, 2021

Wolters Kluwer Health today announced that Tift Regional Medical Center, the flagship hospital of Southwell , a not-for-profit health system in South Central Georgia, has selected POC Advisor for more accurate, earlier detection and treatment of sepsis.

Key Points: 
  • Wolters Kluwer Health today announced that Tift Regional Medical Center, the flagship hospital of Southwell , a not-for-profit health system in South Central Georgia, has selected POC Advisor for more accurate, earlier detection and treatment of sepsis.
  • POC Advisors real-time artificial intelligence (AI) analysis of patient data will further empower Tifts sepsis care capabilities for earlier detection and rapid medical intervention at the earliest onset of sepsis.
  • POC Advisor accounts for more than 4,000 co-morbidities, and the solutions evidence-based algorithms dramatically reduce false positives for conditions that mimic sepsis.
  • At Tift Regional Medical Center, clinicians, including nurses, doctors and advanced practice providers (APP), will receive alerts with evidence-based protocols at the point of care.

Molecular Point-of-Care Market Triples, IVD Market Research Firm Says

Retrieved on: 
Friday, February 5, 2021

ARLINGTON, Va., Feb. 5, 2021 /PRNewswire-PRWeb/ -- Molecular point of care systems were in great demand, and tripled results between 2019 and 2020, according to IVD market research publisher Kalorama Information.

Key Points: 
  • ARLINGTON, Va., Feb. 5, 2021 /PRNewswire-PRWeb/ -- Molecular point of care systems were in great demand, and tripled results between 2019 and 2020, according to IVD market research publisher Kalorama Information.
  • The firm said that sales of reagents and instruments for molecular point-of-care (mPOC) went from $350M in 2019 to $900 in 2020.
  • The finding was made in their latest latest report, The Market and Potential for Molecular Point of Care .
  • The concept of molecular point of care is to mix the accessibility of POC testing with the accuracy of molecular technology.

EBSCO Clinical Decisions Resource DynaMed® Named 2021 Best in KLAS for Clinical Decision Support

Retrieved on: 
Tuesday, February 2, 2021

IPSWICH, Mass., Feb. 2, 2021 /PRNewswire-PRWeb/ -- DynaMed , an EBSCO Clinical Decisions resource, was named the top performing point-of-care clinical reference tool in the 2021 Best in KLAS: Software and Services report.

Key Points: 
  • IPSWICH, Mass., Feb. 2, 2021 /PRNewswire-PRWeb/ -- DynaMed , an EBSCO Clinical Decisions resource, was named the top performing point-of-care clinical reference tool in the 2021 Best in KLAS: Software and Services report.
  • KLAS , a research firm that specializes in monitoring and reporting the performance of healthcare vendors, found that DynaMed was ranked the number one clinical decision support point-of-care reference tool among healthcare organizations.
  • Each year, KLAS publishes the Best in KLAS report, ranking vendors across the many technology and services markets within healthcare.
  • DynaMed, EBSCO Information Services' flagship evidence-based, clinical decision information resource, is designed to reduce time to answer for clinicians and provide the most useful information to healthcare professionals at the point of care.

Arosa, the Premier Integrated Care Management and Home Care Provider in the US, Chooses AxisCare as Software Partner

Retrieved on: 
Tuesday, January 26, 2021

WACO, Texas, Jan. 26, 2021 /PRNewswire-PRWeb/ -- Arosa , formerly Arosa+LivHOME, has chosen award-winning Home Care Software, AxisCare , as its sole point of care software.

Key Points: 
  • WACO, Texas, Jan. 26, 2021 /PRNewswire-PRWeb/ -- Arosa , formerly Arosa+LivHOME, has chosen award-winning Home Care Software, AxisCare , as its sole point of care software.
  • "AxisCare's understanding of the complexities of being an integrated provider of care management and caregiving services was critical to establishing our partnership.
  • They truly are innovative leaders in Home Care and we are honored to have been chosen as their software provider.
  • Arosa is the premier integrated care management and caregiving services provider in the United States.

CheckedUp receives certification from Point of Care Communication Council

Retrieved on: 
Friday, January 22, 2021

Founded by Dr. Richard M Awdeh, CheckedUp is the premierfully digital patient education platform at the point of care.

Key Points: 
  • Founded by Dr. Richard M Awdeh, CheckedUp is the premierfully digital patient education platform at the point of care.
  • CheckedUp offers 100% digital, addressable push devices (Waiting Room TVs + Interactive Exam Room Wallboards) that reach healthcare providers and patients across the US.
  • The Point of Care Communication Council (PoC3), a nonprofit organization focused on advocating for the effective use of the point of care (POC) channel to advance health and healthcare outcomes, recently announced the release of its official Verification and Validation Guidance for 2021.
  • CheckedUp is one of New York's fastest growing healthcare technology growth companies and is the only 100% digital, push technology platform designed for specialty point of care.

Meredith Corporation's John Kenyon Named Co-Chair for Point of Care Communication Council

Retrieved on: 
Monday, January 4, 2021

NEW YORK, Jan. 4,2021 /PRNewswire/ -- Meredith Corporation (NYSE: MDP) today announced Vice President and Managing Director of Meredith Targeted Media Health John Kenyon's election to co-chair of Point of Care Communication Council (PoC3), a nonprofit organization focused on advocating for the effective use of the point of care (POC) channel to advance healthcare outcomes.

Key Points: 
  • NEW YORK, Jan. 4,2021 /PRNewswire/ -- Meredith Corporation (NYSE: MDP) today announced Vice President and Managing Director of Meredith Targeted Media Health John Kenyon's election to co-chair of Point of Care Communication Council (PoC3), a nonprofit organization focused on advocating for the effective use of the point of care (POC) channel to advance healthcare outcomes.
  • Kenyon shares the co-chair position with Richard Awdeh, MD, Chief Executive Officer of CheckedUp, effective immediately.
  • As Vice President and Managing Director of Meredith's Targeted Media Health division, Kenyon oversees all aspects of business development, strategic partnerships and sales.
  • The Point of Care Communication Council (PoC3) exists to advocate for the effective use of the point of care channel to advance health and healthcare outcomes.

Provation, Healthcare IT Leader, Pilots Online Clinical Content Shop Offering Downloadable Evidence-Based Order Sets and Care Plans

Retrieved on: 
Tuesday, December 22, 2020

This unique online store offers hundreds of evidence-based order sets and care plans specific to hundreds of medical conditions from influenza and COVID-19 to cardiac surgery and much more.

Key Points: 
  • This unique online store offers hundreds of evidence-based order sets and care plans specific to hundreds of medical conditions from influenza and COVID-19 to cardiac surgery and much more.
  • We wanted to think outside of the box with the Provation Clinical Content Shop.
  • The Provation Clinical Content Shop includes extensive libraries for Inpatient Order Sets, Outpatient Order Sets, Emergency Order Sets, and Care Plans using the latest evidence and best practices.
  • Provation has a team of dedicated clinicians that ensure the order sets and care plans offered in the Provation Clinical Content Shop are built on the best available evidence to give providers confidence at the point of care.

QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette

Retrieved on: 
Thursday, December 17, 2020

QuantuMDx Group Limited, a UK-based life sciences company developing transformational point-of-care molecular diagnostics, today announced it is investing over 11 million to scale up production to mass manufacture its flagship diagnostic device, Q-POC and disposable test cassette.

Key Points: 
  • QuantuMDx Group Limited, a UK-based life sciences company developing transformational point-of-care molecular diagnostics, today announced it is investing over 11 million to scale up production to mass manufacture its flagship diagnostic device, Q-POC and disposable test cassette.
  • QuantuMDx accelerated development, scale-up and manufacture of Q-POC - its rapid point-of-care testing system - earlier this year in response to the COVID-19 pandemic.
  • Q-POC is a portable, PCR device offering rapid, sample-to-answer, molecular diagnostic testing at the point of care, with results in approximately 30 minutes.
  • The Q-POC system comprises a sample collection kit, single-use test cassette and analyser.

QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette

Retrieved on: 
Thursday, December 17, 2020

QuantuMDx Group Limited, a UK-based life sciences company developing transformational point-of-care molecular diagnostics, today announced it is investing over 11 million to scale up production to mass manufacture its flagship diagnostic device, Q-POC and disposable test cassette.

Key Points: 
  • QuantuMDx Group Limited, a UK-based life sciences company developing transformational point-of-care molecular diagnostics, today announced it is investing over 11 million to scale up production to mass manufacture its flagship diagnostic device, Q-POC and disposable test cassette.
  • QuantuMDx accelerated development, scale-up and manufacture of Q-POC - its rapid point-of-care testing system - earlier this year in response to the COVID-19 pandemic.
  • Q-POC is a portable, PCR device offering rapid, sample-to-answer, molecular diagnostic testing at the point of care, with results in approximately 30 minutes.
  • The Q-POC system comprises a sample collection kit, single-use test cassette and analyser.